SJP 224 (Medent-PE 600 mg-12.5 mg)
Generic Name: guaifenesin/phenylephrine
Pill imprint SJP 224 has been identified as Medent-PE 600 mg-12.5 mg.
Medent-PE is used in the treatment of sinus symptoms; cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Medent-PE 600 mg-12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- guaifenesin/phenylephrine
- Imprint:
- SJP 224
- Strength:
- 600 mg-12.5 mg
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Stewart-Jackson Pharmacal Inc
More about Medent-PE (guaifenesin / phenylephrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Consumer resources
Other brands: Entex LA, Deconex IR, Deconex, Rescon-GG, More... (21)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
